Muscle Endurance: Bodybuilders Turn to CrazyBulk Natural Legal Steroids and BodyBuilding Supplements For Muscle Growth
CrazyBulk
New York City, NY, July 14, 2025 (GLOBE NEWSWIRE) -- As the fitness world continues to evolve, a growing number of athletes and everyday lifters are shifting focus from sheer size to functional strength and muscular endurance. In 2025, this movement is gaining momentum, and one name keeps surfacing at the center of the trend: CrazyBulk. Known for its commitment to natural legal steroids and high-performance muscle building supplements, CrazyBulk is fast becoming the preferred choice for individuals seeking sustainable growth, improved stamina, and accelerated recovery.Unlike outdated synthetic enhancers, CrazyBulk's scientifically backed formulas offer a clean alternative—delivering the power of traditional anabolic compounds without the health risks or legal consequences. Fitness enthusiasts across the United States are reporting increased endurance, sharper focus during workouts, and faster results when stacking these supplements with disciplined training programs.
Industry experts suggest this shift reflects a broader awakening in the bodybuilding community—one that values long-term performance, safety, and real-world application. Whether for competitive sports, daily workouts, or physique refinement, natural legal steroids by CrazyBulk are driving what many are calling the 'Endurance Evolution' of modern muscle building.
The Shift Toward Functional Strength and Endurance in 2025
Gone are the days when bodybuilding was only about raw muscle size and posing aesthetics. In 2025, there's a growing shift toward functional strength and muscular endurance, reflecting a more balanced approach to fitness. From competitive athletes to recreational lifters, more people are now training for performance that lasts—not just for looks that fade. This paradigm shift is transforming the goals of modern fitness enthusiasts and professionals alike.What's fueling this change? Experts cite rising interest in hybrid sports like CrossFit, obstacle course racing, MMA, and functional bodybuilding. These disciplines demand sustained muscle output, oxygen efficiency, and resilience under fatigue—traits not typically emphasized in old-school bulking routines. As a result, athletes are prioritizing recovery speed, energy metabolism, and muscular stamina, recognizing these factors as critical to long-term performance.This is where natural legal steroids, such as those offered by CrazyBulk, come into play. Unlike synthetic compounds, CrazyBulk's formulas are specifically designed to enhance muscular performance without the health risks or testing issues. Products like Clenbutrol and HGH-X2 cater to users who need endurance, fat metabolism, and tissue repair working in sync.Gym culture is evolving with this shift. Workouts now emphasize higher rep ranges, compound movement circuits, and cardiovascular thresholds. More lifters are pushing for rep endurance rather than max lifts. As this evolution unfolds, CrazyBulk stands at the forefront—offering a toolkit of natural performance supplements that meet the demands of this new fitness generation.View official CrazyBulk website for latest best pricing and promotions
Inside the Formulas: What Makes CrazyBulk Bodybuilding Supplements Different?
In a time when performance supplements are under growing scrutiny for banned substances and overhyped claims, CrazyBulk stands out for one reason: formula integrity. Its lineup of natural legal steroids isn't just marketing fluff—it's science-backed, athlete-tested, and strategically designed for muscular endurance, lean growth, and rapid recovery.What makes CrazyBulk different is how each product targets a specific layer of performance. Take Clenbutrol, for instance. Modeled after the once-popular (and now banned) clenbuterol, Clenbutrol leverages natural thermogenics like guarana, bitter orange extract, and Garcinia cambogia. Together, these ingredients help users improve energy output while shedding unwanted fat—critical in maintaining stamina during intense training blocks.Then there's the CrazyBulk Strength Stack—a synergy of four powerful formulas: Testo-Max, D-Bal, Trenorol, and Anvarol. This stack doesn't just build muscle; it supports blood flow, testosterone levels, and ATP regeneration, helping athletes sustain reps under fatigue and recover faster between sessions.Another standout is HGH-X2, formulated with ingredients like maca root, Mucuna pruriens, and hawthorn berry to stimulate natural human growth hormone release. The result? Improved lean mass, accelerated tissue repair, and joint support—especially beneficial for high-frequency endurance trainers.Newer launches like TREN-MAX and WIN-MAX round out CrazyBulk's appeal. TREN-MAX promotes muscle hardness, vascularity, and strength endurance, while WIN-MAX delivers lean power, agility, and explosive output ideal for performance-focused athletes.What's left out of every formula matters, too. No synthetics. No injections. No side effects. CrazyBulk redefines what muscle building supplements can be in the age of safe, long-haul performance.Stacking Strategies: Best Legal Supplement Cycles for Endurance & Performance
In the world of bodybuilding and performance training, stacking—the strategic use of multiple supplements—can significantly amplify endurance, recovery, and output. And in 2025, more athletes are stacking CrazyBulk's natural legal steroids for performance-based goals, not just bulking or shredding.For those prioritizing muscular endurance, the most effective stack starts with Clenbutrol, HGH-X2, and WIN-MAX. This trio works in harmony: Clenbutrol ramps up thermogenesis and energy availability, HGH-X2 supports muscle regeneration and recovery, and WIN-MAX enhances lean muscle retention and stamina during high-volume training. Together, they help athletes push harder and last longer, whether in circuits, high-rep strength work, or intense cardio training.Advanced users often add TREN-MAX to increase muscular hardness and improve strength-endurance output. It's particularly popular among lifters who want to sustain power over longer sets without burnout. For a full-spectrum solution, the CrazyBulk Strength Stack—featuring Testo-Max, D-Bal, TREN-MAX, and Anvarol—delivers a comprehensive boost in testosterone, nitrogen retention, ATP energy levels, and recovery speed.A typical cycle lasts 6 to 8 weeks, with users advised to follow up with a 1- to 2-week off phase. During the cycle, consistent hydration, high-protein nutrition, and sleep optimization are critical for maximizing supplement efficacy.Unlike harsh synthetic steroids, CrazyBulk's stacks are designed for natural synergy, making them suitable for both competitive athletes and everyday fitness warriors. The goal isn't just to go hard—it's to go hard, longer. And with the right stack, endurance isn't a limit—it's a strategy.To review the full supplement facts, ingredient sourcing, and informational materials, visit the official platform.
Natural Recovery Support: How CrazyBulk Supplements Help Muscle Repair
For athletes chasing muscular endurance, recovery isn't optional—it's foundational. Without adequate muscle repair between sessions, stamina breaks down, fatigue builds up, and performance stalls. In 2025, more fitness professionals are turning to CrazyBulk's natural muscle building supplements to close the gap between training and recovery—safely and effectively.
At the heart of CrazyBulk's recovery advantage is HGH-X2, a supplement designed to naturally stimulate the release of human growth hormone. This is essential for muscle tissue repair, protein synthesis, and overall recovery speed. With botanical ingredients like maca root, hawthorn berry, and Mucuna pruriens, HGH-X2 supports overnight regeneration, helping athletes bounce back from grueling sessions without the crash.
Then there's Clenbutrol, a product best known for fat metabolism but equally effective for recovery support. Its thermogenic properties increase oxygen transport and circulation, enhancing nutrient delivery to muscle fibers post-workout. When paired with TREN-MAX or WIN-MAX, users report significantly less soreness, reduced downtime, and more consistent weekly progress.
Recovery is also hormonal—and that's where Testo-Max comes in. By naturally boosting testosterone production, this supplement helps preserve lean muscle during tough training blocks while reducing cortisol's catabolic effects.
Across the board, CrazyBulk's commitment to plant-based, non-synthetic formulas ensures users experience faster recovery without harsh side effects or dependency. Whether you're training for competition or consistency, these recovery-centric supplements are engineered for long-haul performance—keeping you stronger, longer, and injury-free.
Get More Information on Muscle Endurance by Crazybulk From The Official Website
Why Muscle Endurance Matters More After 30: The New Bodybuilding Priority
For athletes over 30, fitness goals evolve. It's no longer just about muscle size—it's about how long the body can perform under stress, recover, and repeat. That's why muscular endurance has become a key priority for this age group. And in 2025, CrazyBulk is answering the call with natural legal steroids that support performance without risking health or hormonal balance.
Aging naturally brings hormonal shifts, slower recovery, and greater susceptibility to injury. But CrazyBulk's line—particularly Testo-Max, HGH-X2, and TREN-MAX—is designed to bridge that biological gap. Testo-Max supports declining testosterone levels, helping users maintain strength, stamina, and metabolic health. Meanwhile, HGH-X2 offers support for muscle repair, joint flexibility, and energy restoration—all crucial for anyone lifting past their 30s.
TREN-MAX also plays a pivotal role. By enhancing oxygen utilization and promoting lean muscle retention, it enables older athletes to train longer without wearing down. These formulas are clean, non-habit-forming, and legal in all 50 states—ideal for users who want to feel powerful again without relying on prescriptions or unsafe methods.
Thousands of men over 30 are already embracing this new performance model. They're not chasing a high—they're chasing longevity. With CrazyBulk, they're finding the support they need to train harder, recover faster, and stay active well beyond what used to be considered a peak age. For today's mature athlete, endurance is the new strength—and CrazyBulk delivers the tools to make it last.How to Start With CrazyBulk for Muscular Endurance in 2025
Whether you're a seasoned athlete or just entering a serious training phase, starting with CrazyBulk for muscular endurance is both strategic and accessible. Designed to replace synthetic enhancers, CrazyBulk's lineup of legal, natural muscle building supplements offers endurance support without the risk of banned substances or harsh side effects.
The first step is goal clarity. Are you looking to extend your workout stamina? Improve recovery between training sessions? Maintain lean muscle during high-volume conditioning? Once identified, your CrazyBulk path becomes simple.
For beginners, a solid entry point is Clenbutrol. Its fat-burning thermogenic properties deliver a noticeable energy boost while aiding oxygen delivery—ideal for circuit or HIIT-style training. Paired with HGH-X2, you'll also start seeing faster recovery, deeper sleep, and more consistent muscle retention.
Intermediate or advanced users may opt for stack-based solutions like the CrazyBulk Strength Stack or build a custom combo with WIN-MAX and TREN-MAX for focused stamina and lean definition. These stacks are designed for synergy, meaning each supplement complements the next for amplified results.
Most users follow 6- to 8-week cycles, with a brief break in between. Products arrive with clear usage instructions, and CrazyBulk's online platform includes stack guides, dosage tips, and cycle planners. There's no guesswork—just a direct route to better endurance and performance.
In a world full of overcomplicated regimens, CrazyBulk offers clarity, compliance, and clean power. The message for 2025 is simple: Endurance isn't optional—it's achievable. And CrazyBulk is how you get there.
Where to Buy: Getting Started With CrazyBulk's Legal Options
As interest in natural legal steroids continues to rise in the U.S. fitness community, one key question keeps surfacing: Where can you safely and reliably buy CrazyBulk products? The answer is refreshingly simple—direct from the official CrazyBulk website, where product authenticity, stack guidance, and cycle support are guaranteed.
Unlike questionable supplement sellers on third-party marketplaces, CrazyBulk operates exclusively through its secure online store. This ensures customers receive genuine formulas, tamper-proof packaging, and real-time customer support. It also allows users to access exclusive bundle pricing, stack kits, and buy-2-get-1-free deals that aren't available elsewhere.
First-time buyers can start with single products like Clenbutrol, Testo-Max, or HGH-X2, all of which include straightforward dosing instructions and suggested stack pairings. For those ready to commit to a full endurance cycle, CrazyBulk offers pre-built stacks curated for fat loss, lean muscle, and strength endurance goals.
Shipping is fast and discreet, with options available across the United States and globally. There are no customs issues, no prescription requirements, and no legal grey areas. Each purchase comes with a 60-day money-back guarantee, giving new users confidence to try the products without financial risk.
In 2025, performance-minded athletes want products that work—without compromise. CrazyBulk offers that promise. For those serious about muscular endurance, recovery, and natural performance enhancement, buying direct from CrazyBulk is the first step in training smarter, longer, and cleaner.
Get More Information on Muscle Endurance by Crazybulk From The Official Website
How Legal Steroids Impact Muscular Recovery: The CrazyBulk Advantage
The secret to lasting endurance isn't just pushing harder—it's recovering smarter. And in 2025, that's where legal steroids from CrazyBulk are transforming the recovery game. Built with performance in mind, these natural supplements address the real issue many lifters face: how to bounce back fast enough to train again tomorrow.Traditional steroid cycles often result in short-term gain with long-term damage—depressing natural hormone function and slowing recovery once off-cycle. CrazyBulk flips that model with plant-based formulas that support the body's natural healing mechanisms. For example, HGH-X2 is formulated to encourage natural human growth hormone production, which helps rebuild muscle tissue, strengthen joints, and reduce soreness.Testo-Max plays a complementary role by supporting testosterone levels, which are essential for muscle protein synthesis and endurance recovery. Low testosterone equals longer recovery time—something Testo-Max directly addresses through ingredients like D-aspartic acid, fenugreek extract, and zinc.When paired with TREN-MAX or Clenbutrol, the benefits expand even further. These supplements increase vascularity and oxygen delivery, helping flush out lactic acid and replenish muscles faster. Athletes who previously needed 48–72 hours to recover are now reporting full bounce-backs in under 36 hours.The end result? More sessions per week, fewer missed lifts, and sustainable long-term progression. With CrazyBulk, recovery isn't an afterthought—it's a built-in feature of every formula. For endurance athletes, that means staying in the game longer, with fewer setbacks and more consistent gains.
Final Thoughts: The Endurance Evolution Has a New Name—CrazyBulk
Muscular endurance is no longer a niche goal—it's become a foundational standard for how athletes train, perform, and recover in today's competitive fitness landscape. Whether it's lifting through fatigue, pushing past mental limits, or recovering fast enough to train the next day, endurance defines progress. And in 2025, the name leading that conversation is CrazyBulk.
By offering a full range of natural legal steroids and muscle building supplements tailored for real-world stamina and strength, CrazyBulk has established itself as a go-to solution for clean performance. Products like Clenbutrol, WIN-MAX, HGH-X2, and the CrazyBulk Strength Stack aren't just about bigger muscles—they're about better output, faster recovery, and sustained drive.
Backed by science, customer testimonials, and global accessibility, CrazyBulk proves that natural supplementation doesn't have to mean sacrificing performance. It means enhancing it—safely, sustainably, and legally. This is performance nutrition for athletes who think beyond vanity, beyond single-rep maxes, and beyond outdated methods.
As more fitness communities embrace endurance training—whether through hybrid lifting, high-rep volume, or functional mobility—CrazyBulk continues to support that shift with formulas that fuel the mission. The endurance revolution isn't coming. It's already here.
For those ready to break limits naturally, CrazyBulk isn't just a brand. It's the new benchmark for what clean, elite performance looks like.
For more information on muscular endurance, educational content, and direct purchasing, visit the official Crazybulk website.
Company Name: Crazybulk244 Madison Avenue,New York City, NY 10016-2817Postal code: NY 10016-2817Media Contact:Full Name - Neil BowersEmail: support@crazybulk.com+1 888-708-6394Company website: https://www.crazybulk.comDisclaimer: The statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Always consult a healthcare professional before taking any dietary supplements.Disclosure: This article is for informational purposes only and does not constitute medical advice. The content may include affiliate links, meaning we may earn a commission if you purchase through recommended links. Always consult a healthcare professional before starting any new supplement regimen.Attachment
CrazyBulk
CONTACT: Company Name: Crazybulk 244 Madison Avenue, New York City, NY 10016-2817 Postal code: NY 10016-2817 Media Contact: Full Name - Neil Bowers Email: support@crazybulk.com +1 888-708-6394 Company website: https://www.crazybulk.comSign in to access your portfolio
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
8 hours ago
- Business Upturn
Sobi Announces U.S. Food and Drug Administration Approves Doptelet® (avatrombopag) for the Treatment of Thrombocytopenia in Pediatric Patients One Year and Older with Persistent or Chronic Immune Thrombocytopenia (ITP)
Doptelet Sprinkle (avatrombopag) was approved as an effective formulation for children one year to less than six years. The primary endpoint was met in 27.8% of patients, confirming the efficacy in children and adolescents with persistent or chronic ITP WALTHAM, Mass., July 25, 2025 (GLOBE NEWSWIRE) — Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi®), today announced that the U.S. Food and Drug Administration (FDA) approved Doptelet® (avatrombopag) for the treatment of thrombocytopenia in pediatric patients one year and older with persistent or chronic immune thrombocytopenia (ITP) who have had an insufficient response to a prior therapy. 1 The approval also includes a new formulation, Doptelet Sprinkle (avatrombopag) oral granules, for use in children ages one to less than six years. 1 'Doptelet represents a significant advancement in the treatment of children and adolescents with persistent or chronic ITP,' said Rachael Grace, MD, MMSc, Pediatric Hematologist and Director, Hematology Clinical Research at Dana-Farber/Boston Children's Cancer and Blood Disorders Center, and lead investigator of the AVA-PED-301 study. 'This therapy offers simple, flexible administration because it is oral, available as a tablet and now as a new pediatric sprinkle formulation and has no food restrictions. The approval of Doptelet for pediatric ITP offers families a new treatment option that can help address challenges in managing ITP in pediatric patients.' Doptelet Sprinkle is the approved dosage form for patients aged one to less than six years, while Doptelet tablet is the approved dosage form for patients aged six and up. 1 The pediatric approval is based on results from AVA-PED-301, a global, randomized, phase 3 study evaluating the efficacy, safety, and pharmacokinetics of Doptelet in the treatment of pediatric subjects with ITP. The study showed that 27.8% of Doptelet patients achieved the primary endpoint of durable platelet response* versus 0% of placebo patients in the absence of rescue medication (p=0.0077, 95% CI 15.8-39.7). Also, 81.5% of Doptelet patients achieved the alternative primary endpoint of platelet response** versus no patients in the placebo group (p=<0.0001, 95% CI 71.1-91.8). At Day 8, 55.6% of Doptelet patients (95% CI: 41.4%, 69.1%) had a platelet count ≥50×10^9/L in the absence of rescue therapy (p<0.0001) versus no placebo patients (95% CI: 0.0%, 16.1%). Doptelet was generally well-tolerated. In pediatric patients with persistent or chronic immune thrombocytopenia, the most common adverse reactions (≥ 10%) were viral infection, nasopharyngitis, cough, pyrexia, and oropharyngeal pain.1 'Since its introduction in 2019, Doptelet has been a cornerstone therapy for chronic ITP in adults,' said Duane Barnes, President of Sobi North America. 'This approval not only reinforces our commitment to innovation but also allows us to expand the treatment experience for patients and their families by offering Doptelet in two formulations.' Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by low numbers of platelets, leading to bruising and an increased risk of bleeding. It is estimated up to 100 people per million live with ITP. In children, ITP occurs in five out of 100,000 children per year and up to 25% of newly diagnosed pediatric ITP patients develop chronic ITP. Currently, no cure is available, and patients usually relapse after various treatments. Indications Doptelet is a thrombopoietin receptor agonist indicated for the treatment of: Thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure. Thrombocytopenia in adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment Thrombocytopenia in pediatric patients 1 year and older with persistent or chronic immune thrombocytopenia who have had an insufficient response to a previous treatment Important Safety Information Doptelet is a thrombopoietin (TPO) receptor agonist and TPO receptor agonists have been associated with thrombotic and thromboembolic complications in patients with chronic liver disease or immune thrombocytopenia. In patients with chronic liver disease, thromboembolic events (portal vein thrombosis) occurred in 0.4% (1/274) of patients receiving Doptelet. In adult patients with chronic immune thrombocytopenia, thromboembolic events (arterial or venous) occurred in 7% (9/128) of patients receiving Doptelet. Doptelet should not be administered to patients with chronic liver disease or immune thrombocytopenia in an attempt to normalize platelet counts. The most common adverse reactions in clinical trials were viral infection, nasopharyngitis, cough, pyrexia, and oropharyngeal pain. To report SUSPECTED ADVERSE REACTIONS, contact Sobi, Inc. at 1-866-773-5274 or FDA at 1-800-FDA-1088 or Please see the full Prescribing Information for Doptelet. * A durable response consisted of patients achieving a platelet count >=50,000/uL for six of the last eight weeks in the 12-week core phase of the AVA-PED-301 study. ** Efficacy was also evaluated by platelet response, defined as the proportion of subjects achieving at least two consecutive platelet assessments ≥50×10^9/L in the core phase in the absence of rescue medication. About Immune thrombocytopenia (ITP) Immune thrombocytopenia (ITP) is a rare, acquired autoimmune condition characterized by a low platelet count and an increased risk of bleeding, and represents a multi-faceted disease burden for children and adolescents. Bleeding can range from minor symptoms, such as bruising, to more severe findings such as intracranial hemorrhage. ITP can also have a significant impact on quality of life including severe fatigue and restrictions on physical activity due to risk of bleeding. About Doptelet® (avatrombopag) Doptelet is an orally administered thrombopoietin receptor agonist (TPO-RA) that mimics the biologic effects of TPO in stimulating the development and maturation of megakaryocytes, resulting in increased platelet count. It is approved by the US Food & Drug Administration (FDA) for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure and by the European Medicines Agency (EMA) for the treatment of severe thrombocytopenia in adult patients with chronic liver disease (CLD) who are scheduled to undergo an invasive procedure. In June 2019, Doptelet was approved by the FDA for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment and in 2021, Doptelet was approved by EMA for the treatment of primary chronic ITP in adult patients who are refractory to other treatments (e.g. corticosteroids, immunoglobulins). About Sobi North America As the North American affiliate of international biopharmaceutical company Sobi, the Sobi North America team is committed to Sobi's vision of being a leader in providing innovative treatments that transform lives for individuals with rare diseases. Our product portfolio includes multiple approved treatments focused on immunology, hematology and specialty care. With U.S. headquarters in the Boston area, Canadian headquarters in the Toronto area, and field sales, medical and market access representatives spanning North America, our growing team has a proven track record of commercial excellence. More information is available at or at About Sobi® Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases. Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2024, revenue amounted to SEK 26 billion. Sobi's share (STO:SOBI) is listed on Nasdaq Stockholm. More about Sobi at and LinkedIn. Contacts For details on how to contact the Sobi Investor Relations Team, please click here. For Sobi Media, click here. References 1. Doptelet Prescribing Information. Doptelet U.S. Product Information. Last updated: July 2025. Morrisville, NC: AkaRx, Inc. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
Yahoo
8 hours ago
- Yahoo
Wellcome Photography Prize 2025: Winning Images Reveal Powerful Stories of Science and Health
Sujata Setia, Mithail Afrige Chowdhury and Steve Gschmeissner awarded £10,000 each for images exploring domestic abuse, climate migration and the hidden dangers of cholesterol A Thousand Cuts, Sujata Setia, 2023, Urban Travel, Mithail Afrige Chowdhury, 2023, Cholesterol in the Liver, 2022, Steve Gschmeissner Click Here to download press images and captions LONDON, July 25, 2025 (GLOBE NEWSWIRE) -- Wellcome's 2025 Photography Prize celebrates three image makers whose work reveals the human stories behind science and health. UK-based artist Sujata Setia, Bangladeshi documentary and street photographer Mithail Afrige Chowdhury, and UK-based electron microscopy specialist and science photographer Steve Gschmeissner have each been awarded a £10,000 prize for powerful images that reflect how science and health shape people's lives in complex and deeply personal ways, from the from the hidden toll of domestic abuse to the everyday realities of climate migration, to the microscopic processes that underpin heart disease. Now in its 28th year, the Wellcome Photography Prize celebrates compelling imagery at the intersection of science, health and human experience. From documentary photography to microscopy and medical imaging, it highlights diverse perspectives on global health and the vital role of visual storytelling in creating a healthier future. The top 25 entries are now on display in the Wellcome Photography Prize 2025 exhibition, which is free and open to the public at the Francis Crick Institute in London, running until 18 October 2025. Each of the finalists has received a £1,000 prize, with a total of £52,000 awarded across the competition. Lara Clements, Associate Director, Engagement, Wellcome, says, 'The Wellcome Photography Prize offers image-makers a platform to showcase the impact of science and health on lives around the world. This year's winning works stood out not only for their technical accomplishment, but for the care and collaboration behind them. Sujata Setia's portraits raised powerful questions around dignity, confidentiality and sensitivity. Mithail Afrige Chowdhury's image exemplified the value of being embedded in the community and explored themes of adaptation, illusion and fantasy in a compelling way. Steve Gschmeissner's biomedical image impressed us with its precision and raised important questions about how scientific imagery is shared and understood by the public. We hope audiences will find the winners' work moving, educational and inspiring, and enjoy the full exhibition at the Francis Crick Institute.' The Winners In the Storytelling Series category, Sujata Setia was recognised for A Thousand Cuts, a deeply collaborative portrait project developed with survivors of domestic abuse within South Asian communities. Each image is a composite of personal testimony, visual symbolism, and traditional craft. Setia worked with the women and with the charity SHEWISE to create portraits that protected anonymity without erasing identity, applying the Indian paper-cutting technique sanjhi to overlay each photograph. The results are intimate, powerful reflections on generational trauma, silence, survival, and the politics of representation. From the account of a woman forced into marriage twice by her father and left with lasting PTSD, to a mother determined to break the cycle of violence for her daughter, the series captures how abuse can become ingrained and normalised, and how art can offer a means of reclaiming narrative. Sujata Setia says, 'This is a monumental recognition. A Thousand Cuts being selected for Wellcome Photography Prize affirms that health cannot be separated from the histories that shape it. And that domestic abuse is never a singular event; it leaves a direct, trans-generational imprint on health. As a child who grew up in a home where violence was a daily occurrence, I carry that trauma like another limb. This recognition validates not just my story, but the invisible, intangible, yet deeply scarring legacy of gender-based abuse. Domestic abuse is one of the most widespread global crimes; and yet remains among the least publicly acknowledged health crises. I hope this moment becomes a catalyst for deeper dialogue and scholarship around the interrelation between domestic abuse and health. That is our collective hope.' Mithail Afrige Chowdhury was awarded the Striking Solo Photography prize for Urban Travel, a deceptively gentle image of a mother and daughter on a rooftop picnic in Dhaka. With few parks left in the city due to rapid urbanisation, this staged moment, a simple attempt to give a child a taste of nature, becomes an act of resilience. Nearly half of Dhaka's population today are climate migrants, displaced by increasingly extreme weather, and Chowdhury's work highlights the everyday consequences of these shifts: the loss of green space, of childhood rituals, of breath. The photograph is tender, composed, and yet filled with tension, a portrait of care and adaptation under invisible pressures. Mithail Afrige Chowdhury says, 'When I got the news, the first thing I did was charge my camera—not to take a photo, but to restart something I thought I'd lost. I won't dwell on personal or professional hardships, but this moment means more than I can say. I made this image two years ago, as part of a major project on climate change, urban sustainability, and public health. Then life intervened, and fear slowly pulled me away from the work I loved. But now, I can wake up with an objective. Because someone has my back. And that makes all the difference. Awards can feel technical but this recognition from Wellcome feels deeply human.' The winner of The Marvels of Scientific and Medical Imaging was announced as Steve Gschmeissner, whose electron microscopy image Cholesterol in the Liver reveals cholesterol crystals (shown in blue) forming inside lipid-laden liver cells (purple). These microscopic shifts, invisible to the naked eye, can have deadly consequences: when cholesterol hardens from liquid to crystal, it damages blood vessels and contributes to heart disease and strokes. Gschmeissner's colourised SEM image transforms this biological process into something visually striking, part data, part artwork. With a career spanning over four decades, and more than 10,000 images published in scientific journals, stamp collections, fashion collaborations, and music albums, his work exemplifies how imaging can bridge science and culture. Steve Gschmeissner says, 'When I discovered that Wellcome had reintroduced the Marvels of Scientific and Medical Imaging category, I was delighted to enter such a prestigious competition. I was thrilled to be shortlisted, and winning first prize is undoubtedly one of the highlights of my 50-year career of trying to bring the wonders of the microscopic world to all.' This year's prize drew submissions from over 100 countries. The Top 25 entries featured over 30 individuals from 18 countries, spanning Bangladesh, Brazil, France, Germany, Greece, India, Italy, Myanmar, Peru, South Africa, Spain, Uganda, the UK, USA and beyond. The winners were selected by an international judging panel comprising leading voices from photography, science, health and journalism. The panel was chaired by Melanie Keen, Director of Wellcome Collection, and included Caroline Hunter, Picture Editor at The Guardian; Daniella Zalcman, Photographer and Founder of Women Photograph; Benjamin Ryan, Independent Science Journalist; Elizabeth Wathuti, Environmental and Climate Activist; Esmita Charani, Associate Professor at the University of Cape Town; Helen Fisher, Professor of Developmental Psychopathology at King's College London; Noah Green, Science Educator at the Beautiful Biology Initiative; and Mark Lythgoe, Director of the UCL Centre for Advanced Biomedical Imaging. Wellcome Photography Prize Exhibition Curated by Laurie Britton Newell and Ligaya Salazar, the Wellcome Photography Prize exhibition features images that reflect a wide spectrum of health experiences, from everyday routines to global challenges. Using techniques such as portraiture, cyanotypes, drone photography, and light and electron microscopy, the image makers show how health is lived, documented and researched around the world. Many of the works respond to Wellcome's core focus areas, mental health, climate and health, infectious disease and discovery research. Together, they reveal how these issues overlap and take shape in different cultural and geographic contexts. The result is a layered and often unexpected portrait of health today, told through voices and perspectives that are frequently overlooked. Among this year's highlights are Marks of Majesty: Vanessa by Julia Comita and Stephanie Francis, a portrait honouring the life and choices of a person impacted by breast cancer who opted for aesthetic flat closure, challenging assumptions around gender, illness and identity. Beautiful Disaster by Alexandru Radu Popescu shows a lake of toxic mining waste in Romania that continues to expand each year, an image of both striking beauty and environmental damage. Resilience Artist by Pyaephyo Thetpaing captures a craftsman in Myanmar who creates lacquerware using his foot, offering a broader reflection on health, disability and the role of cultural tradition in healing. In the scientific imaging category, Ice and Fire Chronics by Ingrid Augusto, Kildare Rocha de Miranda and Vânia da Silva Vieira shows the structure of the parasite that causes Chagas disease, which affects millions across the Americas. Blooming Barrier by Lucy Holland presents goblet cells inside the gut of a child with Hirschsprung's disease, offering insight into how cell structures influence lifelong digestive health. From Butterflies to Humans by Amaia Alcalde Anton reveals the brain of a butterfly mid-metamorphosis, part of a study into neurogenesis with implications for human brain development. In addition to the Top 25 entries, the exhibition also features Things We Left Unseen, a youth-led photography project developed by Cape Town-based public health organisation Eh!woza. Created in collaboration with young people in the township of Khayelitsha, the project explores health, stigma, and daily life through the eyes of a generation growing up with high HIV and TB burdens, but also with hope and agency. The exhibition is hosted at the Francis Crick Institute, reflecting a shared commitment to making science more visible through culture. Ali Bailey, Director of Communications and Public Engagement at the Francis Crick Institute, said: 'We are delighted to host the top images from the Wellcome Photography Prize, showcasing the power of visual storytelling in health and science. The images explore a number of themes that resonate with Crick research, from the health effects of air pollution to neurogenesis. We hope visitors will be moved by the stories behind these incredible photos and also inspired by how beautiful science can be.' Notes to Editors: Media Contacts Sophie Balfour-LynnSuttonSophiebl@ Mary-Kate FindonWellcomemediaoffice@ Winners' Biographies Sujata Setia (Storytelling Series) Sujata Setia is an Indian-born, UK-based artist who's socially engaged, research-led practice combines photography with traditional artistic interventions to explore subaltern histories, cultural imperialism, and the politics of representation. With a background in journalism and a Master's in International Relations from King's College London, her work draws on academic research and community collaboration to centre marginalised voices, particularly through a feminist lens. Her acclaimed series Changing the Conversation marked a shift away from her earlier portraiture, interrogating the cultural and political construction of beauty. In 2024, she was awarded the Culture King's Grant to develop a lens-based, interdisciplinary project exploring the role of workplace structures for embroidery women artisans in Kashmir. She also recently received the Centre for British Photography Realisation Grant to further expand the scope of A Thousand Cuts, a powerful body of work amplifying the voices of survivors of gender-based abuse. Setia's work has received major international recognition, including the Sony World Photography Award (Creative category, 2024), LensCulture Critics' Choice Award (2024), Prix Pictet nomination (2023), BJP Female in Focus (2022), and Photographer of the Year at the Tokyo International Foto Awards (2021). Her photography has been exhibited widely—from Somerset House in London to Times Square in New York—and featured in leading publications including The Guardian, CNN, BBC, and Forbes. Beyond her visual practice, Setia contributes to education and advocacy through teaching ethical storytelling and photography at EFTI in Madrid, and through collaborations with organisations such as SHEWISE and WERESTART in the UK. Her work consistently seeks to reshape public narratives around identity, power, and care through interdisciplinary, justice-focused art. Mithail Afrige Chowdhury (Striking Solo Photography) Mithail Afrige Chowdhury is a documentary and street photographer based in Dhaka, Bangladesh. Raised in the city of Khulna, his photography is deeply rooted in the lives of ordinary people. 'Since then, I have always tried to understand people's lives—their pain, joy, and the complexities shaped by social, economic, political, and environmental changes.' He began photography in 2015 and chose to document what he knew best: life around him. His work has captured the Rohingya refugee crisis, the effects of climate change on Bangladesh (an ongoing project), major festivals, urban water crises, slum fires, and the Covid-19 pandemic. Mithail has won numerous international photography awards, including the Life Press Photo Award (Ukraine), Xposure International Photography Competition (UAE), Compass Photo Competition by the University of Oxford (UK), and contests in China. His work has been featured in The Guardian, The Daily Sun, The Times of India, Global Photography, and publications from the University of Oxford, ASCE, and Saturday Magazine. Steve Gschmeissner (The Marvels of Medical and Scientific Imaging) Steve Gschmeissner is a UK-based photographer and electron microscopy specialist whose career spans over four decades in scientific imaging. After earning a degree in Zoology, he spent 25 years at the Royal College of Surgeons, eventually leading the electron microscopy services, followed by 15 years leading the EM unit at Cancer Research UK. In 2002, Gschmeissner retired early to dedicate himself to freelance photography, specialising in Scanning Electron Microscopy (SEM). Over the past two decades, he has built an archive of more than 10,000 images, widely published across scientific, medical, and popular media. His work has featured in everything from textbooks and advertising to art, fashion, and music, appearing on album covers for Peter Gabriel, artworks by Damien Hirst, on US Postal Service stamps, and as visual inspiration for an Iris van Herpen's fashion collection. In 2021, he was awarded the Lennart Nilsson Award for his lifelong contribution to microscopy. His images continue to bridge the worlds of science and visual culture, offering new ways of seeing the invisible. Full list of Finalists - Top 25 Entries Striking solo photography Searching for Life – Sandipani Chattopadhyay (India) Urban Travel – Mithail Afrige Chowdhury (Bangladesh) Marks of Majesty: Vanessa – Julia Comita & Stephanie Francis (USA) Musa – Marijn Fidder (Uganda/Netherlands) The Light Will Come – Dora Grivopoulou (Greece) Cricket is My Emotion – Ziaul Huque (Bangladesh) Pie-by-Sam – Reatile Moalusi (South Africa) Beautiful Disaster – Alexandru Radu Popescu (Romania) Resilience Artist – Pyaephyo Thetpaing (Myanmar) Stereo EEG Self-Portrait – Muir Vidler (UK) Transparent Curtains – Oded Wagenstein (Israel) Self, Five Years On – Georgie Wileman (UK) A storytelling series The Loss Mother's Stone – Nancy Borowick (US Virgin Islands) A Dream to Cure Water – Ciril Jazbec (UK) Nemo's Garden – Giacomo d'Orlando (Italy) A Thousand Cuts – Sujata Setia (UK) I Spend 150 Hours Alone Each Week – Madeleine Waller (Australia/UK) The marvels of scientific and medical imaging From Butterflies to Humans – Amaia Alcalde Anton (UK) Ice and Fire Chronics: The Chagas Disease Invader – Ingrid Augusto, Kildare Rocha de Miranda & Vânia da Silva Vieira (Brazil) Cholesterol in the Liver – Steve Gschmeissner (UK) Blooming Barrier – Lucy Holland (UK) Submarine Fever – Jander Matos & Joaquim Nascimento (Brazil) Organoids – Oliver Meckes & Nicole Ottawa, Eye of Science (Germany) I've Got You, Under My Skin: Microplastics in Mammalian Tissue – P. Stephen Patrick & Olumide Ogunlade (UK) Brixton Road, Lambeth – Marina Vitaglione (France/UK) Exhibition Details Wellcome Photography Prize 2025 exhibition is curated by Laurie Britton Newell and Ligaya SalazarAt the Francis Crick Institute, 1 Midland Road, London, NW1 1AT17 July – 18 October 2025Open Wednesdays to Saturdays, 10am-4pm (Wednesdays until 8pm)Admission free About Wellcome Wellcome supports science to solve the urgent health challenges facing everyone. We support discovery research into life, health and wellbeing, and we're taking on three worldwide health challenges: mental health, infectious disease and climate and health. Follow the prize:Instagram: @wellcomephotoprize Wellcome Photography Prize 2025 | Wellcome About the Francis Crick Institute We are delighted that the Crick are hosting this year's Wellcome Photography Prize exhibition. The Francis Crick Institute is a biomedical discovery institute with the mission of understanding the fundamental biology underlying health and disease. Its work helps improve our understanding of why disease develops which promotes discoveries into new ways to prevent, diagnose and treat disease. An independent organisation, its founding partners are the Medical Research Council (MRC), Cancer Research UK, Wellcome, UCL (University College London), Imperial College London and King's College London. The Crick was formed in 2015, and in 2016 it moved into a brand new state-of-the-art building in central London which brings together 1500 scientists and support staff working collaboratively across disciplines, making it the biggest biomedical research facility under a single roof in Europe. A photo accompanying this announcement is available at
Business Upturn
8 hours ago
- Business Upturn
Wellcome Photography Prize 2025: Winning Images Reveal Powerful Stories of Science and Health
By GlobeNewswire Published on July 25, 2025, 15:19 IST A Thousand Cuts, Sujata Setia, 2023, Urban Travel, Mithail Afrige Chowdhury, 2023, Cholesterol in the Liver, 2022, Steve Gschmeissner Click Here to download press images and captions LONDON, July 25, 2025 (GLOBE NEWSWIRE) — Wellcome's 2025 Photography Prize celebrates three image makers whose work reveals the human stories behind science and health. UK-based artist Sujata Setia, Bangladeshi documentary and street photographer Mithail Afrige Chowdhury, and UK-based electron microscopy specialist and science photographer Steve Gschmeissner have each been awarded a £10,000 prize for powerful images that reflect how science and health shape people's lives in complex and deeply personal ways, from the from the hidden toll of domestic abuse to the everyday realities of climate migration, to the microscopic processes that underpin heart disease. Now in its 28th year, the Wellcome Photography Prize celebrates compelling imagery at the intersection of science, health and human experience. From documentary photography to microscopy and medical imaging, it highlights diverse perspectives on global health and the vital role of visual storytelling in creating a healthier future. The top 25 entries are now on display in the Wellcome Photography Prize 2025 exhibition, which is free and open to the public at the Francis Crick Institute in London, running until 18 October 2025. Each of the finalists has received a £1,000 prize, with a total of £52,000 awarded across the competition. Lara Clements, Associate Director, Engagement, Wellcome, says, ' The Wellcome Photography Prize offers image-makers a platform to showcase the impact of science and health on lives around the world. This year's winning works stood out not only for their technical accomplishment, but for the care and collaboration behind them. Sujata Setia's portraits raised powerful questions around dignity, confidentiality and sensitivity. Mithail Afrige Chowdhury's image exemplified the value of being embedded in the community and explored themes of adaptation, illusion and fantasy in a compelling way. Steve Gschmeissner's biomedical image impressed us with its precision and raised important questions about how scientific imagery is shared and understood by the public. We hope audiences will find the winners' work moving, educational and inspiring, and enjoy the full exhibition at the Francis Crick Institute.' The Winners In the Storytelling Series category, Sujata Setia was recognised for A Thousand Cuts , a deeply collaborative portrait project developed with survivors of domestic abuse within South Asian communities. Each image is a composite of personal testimony, visual symbolism, and traditional craft. Setia worked with the women and with the charity SHEWISE to create portraits that protected anonymity without erasing identity, applying the Indian paper-cutting technique sanjhi to overlay each photograph. The results are intimate, powerful reflections on generational trauma, silence, survival, and the politics of representation. From the account of a woman forced into marriage twice by her father and left with lasting PTSD, to a mother determined to break the cycle of violence for her daughter, the series captures how abuse can become ingrained and normalised, and how art can offer a means of reclaiming narrative. Sujata Setia says, ' This is a monumental recognition. A Thousand Cuts being selected for Wellcome Photography Prize affirms that health cannot be separated from the histories that shape it. And that domestic abuse is never a singular event; it leaves a direct, trans-generational imprint on health. As a child who grew up in a home where violence was a daily occurrence, I carry that trauma like another limb. This recognition validates not just my story, but the invisible, intangible, yet deeply scarring legacy of gender-based abuse. Domestic abuse is one of the most widespread global crimes; and yet remains among the least publicly acknowledged health crises. I hope this moment becomes a catalyst for deeper dialogue and scholarship around the interrelation between domestic abuse and health. That is our collective hope.' Mithail Afrige Chowdhury was awarded the Striking Solo Photography prize for Urban Travel , a deceptively gentle image of a mother and daughter on a rooftop picnic in Dhaka. With few parks left in the city due to rapid urbanisation, this staged moment, a simple attempt to give a child a taste of nature, becomes an act of resilience. Nearly half of Dhaka's population today are climate migrants, displaced by increasingly extreme weather, and Chowdhury's work highlights the everyday consequences of these shifts: the loss of green space, of childhood rituals, of breath. The photograph is tender, composed, and yet filled with tension, a portrait of care and adaptation under invisible pressures. Mithail Afrige Chowdhury says, ' When I got the news, the first thing I did was charge my camera—not to take a photo, but to restart something I thought I'd lost. I won't dwell on personal or professional hardships, but this moment means more than I can say. I made this image two years ago, as part of a major project on climate change, urban sustainability, and public health. Then life intervened, and fear slowly pulled me away from the work I loved. But now, I can wake up with an objective. Because someone has my back. And that makes all the difference. Awards can feel technical but this recognition from Wellcome feels deeply human.' The winner of The Marvels of Scientific and Medical Imaging was announced as Steve Gschmeissner, whose electron microscopy image Cholesterol in the Liver reveals cholesterol crystals (shown in blue) forming inside lipid-laden liver cells (purple). These microscopic shifts, invisible to the naked eye, can have deadly consequences: when cholesterol hardens from liquid to crystal, it damages blood vessels and contributes to heart disease and strokes. Gschmeissner's colourised SEM image transforms this biological process into something visually striking, part data, part artwork. With a career spanning over four decades, and more than 10,000 images published in scientific journals, stamp collections, fashion collaborations, and music albums, his work exemplifies how imaging can bridge science and culture. Steve Gschmeissner says, ' When I discovered that Wellcome had reintroduced the Marvels of Scientific and Medical Imaging category, I was delighted to enter such a prestigious competition. I was thrilled to be shortlisted, and winning first prize is undoubtedly one of the highlights of my 50-year career of trying to bring the wonders of the microscopic world to all.' This year's prize drew submissions from over 100 countries. The Top 25 entries featured over 30 individuals from 18 countries, spanning Bangladesh, Brazil, France, Germany, Greece, India, Italy, Myanmar, Peru, South Africa, Spain, Uganda, the UK, USA and beyond. The winners were selected by an international judging panel comprising leading voices from photography, science, health and journalism. The panel was chaired by Melanie Keen, Director of Wellcome Collection, and included Caroline Hunter, Picture Editor at The Guardian ; Daniella Zalcman, Photographer and Founder of Women Photograph; Benjamin Ryan, Independent Science Journalist; Elizabeth Wathuti, Environmental and Climate Activist; Esmita Charani, Associate Professor at the University of Cape Town; Helen Fisher, Professor of Developmental Psychopathology at King's College London; Noah Green, Science Educator at the Beautiful Biology Initiative; and Mark Lythgoe, Director of the UCL Centre for Advanced Biomedical Imaging. Wellcome Photography Prize Exhibition Curated by Laurie Britton Newell and Ligaya Salazar, the Wellcome Photography Prize exhibition features images that reflect a wide spectrum of health experiences, from everyday routines to global challenges. Using techniques such as portraiture, cyanotypes, drone photography, and light and electron microscopy, the image makers show how health is lived, documented and researched around the world. Many of the works respond to Wellcome's core focus areas, mental health, climate and health, infectious disease and discovery research. Together, they reveal how these issues overlap and take shape in different cultural and geographic contexts. The result is a layered and often unexpected portrait of health today, told through voices and perspectives that are frequently overlooked. Among this year's highlights are Marks of Majesty: Vanessa by Julia Comita and Stephanie Francis, a portrait honouring the life and choices of a person impacted by breast cancer who opted for aesthetic flat closure, challenging assumptions around gender, illness and identity. Beautiful Disaster by Alexandru Radu Popescu shows a lake of toxic mining waste in Romania that continues to expand each year, an image of both striking beauty and environmental damage. Resilience Artist by Pyaephyo Thetpaing captures a craftsman in Myanmar who creates lacquerware using his foot, offering a broader reflection on health, disability and the role of cultural tradition in healing. In the scientific imaging category, Ice and Fire Chronics by Ingrid Augusto, Kildare Rocha de Miranda and Vânia da Silva Vieira shows the structure of the parasite that causes Chagas disease, which affects millions across the Americas. Blooming Barrier by Lucy Holland presents goblet cells inside the gut of a child with Hirschsprung's disease, offering insight into how cell structures influence lifelong digestive health. From Butterflies to Humans by Amaia Alcalde Anton reveals the brain of a butterfly mid-metamorphosis, part of a study into neurogenesis with implications for human brain development. In addition to the Top 25 entries, the exhibition also features Things We Left Unseen , a youth-led photography project developed by Cape Town-based public health organisation Eh!woza. Created in collaboration with young people in the township of Khayelitsha, the project explores health, stigma, and daily life through the eyes of a generation growing up with high HIV and TB burdens, but also with hope and agency. The exhibition is hosted at the Francis Crick Institute, reflecting a shared commitment to making science more visible through culture. Ali Bailey, Director of Communications and Public Engagement at the Francis Crick Institute, said: ' We are delighted to host the top images from the Wellcome Photography Prize, showcasing the power of visual storytelling in health and science. The images explore a number of themes that resonate with Crick research, from the health effects of air pollution to neurogenesis. We hope visitors will be moved by the stories behind these incredible photos and also inspired by how beautiful science can be.' Notes to Editors: Media Contacts Sophie Balfour-LynnSutton [email protected] Mary-Kate FindonWellcome [email protected] Winners' Biographies Sujata Setia (Storytelling Series) Sujata Setia is an Indian-born, UK-based artist who's socially engaged, research-led practice combines photography with traditional artistic interventions to explore subaltern histories, cultural imperialism, and the politics of representation. With a background in journalism and a Master's in International Relations from King's College London, her work draws on academic research and community collaboration to centre marginalised voices, particularly through a feminist lens. Her acclaimed series Changing the Conversation marked a shift away from her earlier portraiture, interrogating the cultural and political construction of beauty. In 2024, she was awarded the Culture King's Grant to develop a lens-based, interdisciplinary project exploring the role of workplace structures for embroidery women artisans in Kashmir. She also recently received the Centre for British Photography Realisation Grant to further expand the scope of A Thousand Cuts , a powerful body of work amplifying the voices of survivors of gender-based abuse. Setia's work has received major international recognition, including the Sony World Photography Award (Creative category, 2024), LensCulture Critics' Choice Award (2024), Prix Pictet nomination (2023), BJP Female in Focus (2022), and Photographer of the Year at the Tokyo International Foto Awards (2021). Her photography has been exhibited widely—from Somerset House in London to Times Square in New York—and featured in leading publications including The Guardian , CNN , BBC , and Forbes . Beyond her visual practice, Setia contributes to education and advocacy through teaching ethical storytelling and photography at EFTI in Madrid, and through collaborations with organisations such as SHEWISE and WERESTART in the UK. Her work consistently seeks to reshape public narratives around identity, power, and care through interdisciplinary, justice-focused art. Mithail Afrige Chowdhury (Striking Solo Photography) Mithail Afrige Chowdhury is a documentary and street photographer based in Dhaka, Bangladesh. Raised in the city of Khulna, his photography is deeply rooted in the lives of ordinary people. 'Since then, I have always tried to understand people's lives—their pain, joy, and the complexities shaped by social, economic, political, and environmental changes.' He began photography in 2015 and chose to document what he knew best: life around him. His work has captured the Rohingya refugee crisis , the effects of climate change on Bangladesh (an ongoing project), major festivals, urban water crises, slum fires, and the Covid-19 pandemic. Mithail has won numerous international photography awards, including the Life Press Photo Award (Ukraine), Xposure International Photography Competition (UAE), Compass Photo Competition by the University of Oxford (UK), and contests in China. His work has been featured in The Guardian , The Daily Sun , The Times of India , Global Photography , and publications from the University of Oxford , ASCE , and Saturday Magazine . Steve Gschmeissner (The Marvels of Medical and Scientific Imaging) Steve Gschmeissner is a UK-based photographer and electron microscopy specialist whose career spans over four decades in scientific imaging. After earning a degree in Zoology, he spent 25 years at the Royal College of Surgeons, eventually leading the electron microscopy services, followed by 15 years leading the EM unit at Cancer Research UK. In 2002, Gschmeissner retired early to dedicate himself to freelance photography, specialising in Scanning Electron Microscopy (SEM). Over the past two decades, he has built an archive of more than 10,000 images, widely published across scientific, medical, and popular media. His work has featured in everything from textbooks and advertising to art, fashion, and music, appearing on album covers for Peter Gabriel, artworks by Damien Hirst, on US Postal Service stamps, and as visual inspiration for an Iris van Herpen's fashion collection. In 2021, he was awarded the Lennart Nilsson Award for his lifelong contribution to microscopy. His images continue to bridge the worlds of science and visual culture, offering new ways of seeing the invisible. Full list of Finalists – Top 25 Entries Striking solo photography Searching for Life – Sandipani Chattopadhyay (India) Urban Travel – Mithail Afrige Chowdhury (Bangladesh) Marks of Majesty: Vanessa – Julia Comita & Stephanie Francis (USA) Musa – Marijn Fidder (Uganda/Netherlands) The Light Will Come – Dora Grivopoulou (Greece) Cricket is My Emotion – Ziaul Huque (Bangladesh) Pie-by-Sam – Reatile Moalusi (South Africa) Beautiful Disaster – Alexandru Radu Popescu (Romania) Resilience Artist – Pyaephyo Thetpaing (Myanmar) Stereo EEG Self-Portrait – Muir Vidler (UK) Transparent Curtains – Oded Wagenstein (Israel) Self, Five Years On – Georgie Wileman (UK) A storytelling series The Loss Mother's Stone – Nancy Borowick (US Virgin Islands) A Dream to Cure Water – Ciril Jazbec (UK) Nemo's Garden – Giacomo d'Orlando (Italy) A Thousand Cuts – Sujata Setia (UK) I Spend 150 Hours Alone Each Week – Madeleine Waller (Australia/UK) The marvels of scientific and medical imaging From Butterflies to Humans – Amaia Alcalde Anton (UK) Ice and Fire Chronics: The Chagas Disease Invader – Ingrid Augusto, Kildare Rocha de Miranda & Vânia da Silva Vieira (Brazil) Cholesterol in the Liver – Steve Gschmeissner (UK) Blooming Barrier – Lucy Holland (UK) Submarine Fever – Jander Matos & Joaquim Nascimento (Brazil) Organoids – Oliver Meckes & Nicole Ottawa, Eye of Science (Germany) I've Got You, Under My Skin: Microplastics in Mammalian Tissue – P. Stephen Patrick & Olumide Ogunlade (UK) Brixton Road, Lambeth – Marina Vitaglione (France/UK) Exhibition Details Wellcome Photography Prize 2025 exhibition is curated by Laurie Britton Newell and Ligaya SalazarAt the Francis Crick Institute, 1 Midland Road, London, NW1 1AT17 July – 18 October 2025Open Wednesdays to Saturdays, 10am-4pm (Wednesdays until 8pm) Admission free About Wellcome Wellcome supports science to solve the urgent health challenges facing everyone. We support discovery research into life, health and wellbeing, and we're taking on three worldwide health challenges: mental health, infectious disease and climate and health. Follow the prize: Instagram: @wellcomephotoprize Wellcome Photography Prize 2025 | Wellcome About the Francis Crick Institute We are delighted that the Crick are hosting this year's Wellcome Photography Prize exhibition. The Francis Crick Institute is a biomedical discovery institute with the mission of understanding the fundamental biology underlying health and disease. Its work helps improve our understanding of why disease develops which promotes discoveries into new ways to prevent, diagnose and treat disease. An independent organisation, its founding partners are the Medical Research Council (MRC), Cancer Research UK, Wellcome, UCL (University College London), Imperial College London and King's College London. The Crick was formed in 2015, and in 2016 it moved into a brand new state-of-the-art building in central London which brings together 1500 scientists and support staff working collaboratively across disciplines, making it the biggest biomedical research facility under a single roof in Europe. A photo accompanying this announcement is available at Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
